Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Mackenzie, Isla S, Ford, Ian, Nuki, George, Hallas, Jesper, Hawkey, Christopher J, Webster, John, Ralston, Stuart H, Walters, Matthew, Robertson, Michele, De Caterina, Raffaele, Findlay, Evelyn, PerezЖурнал:
The Lancet
DOI:
10.1016/S0140-6736(20)32234-0
Date:
November, 2020
Файл:
PDF, 633 KB
2020